Age- and transgene-related changes in regional cerebral metabolism in PSAPP mice

In parallel to imaging studies in humans with Alzheimer's disease (AD), we have mapped brain metabolic activity in transgenic mouse models of AD. Our aim in both is to provide new surrogate markers of progression to help clarify disease mechanisms and rapidly screen candidate therapeutics. Since previous findings of preferential reductions in posterior cingulate glucose metabolism may have been confounded by morphological abnormalities in previously studied "PDAPP" transgenic mice, we first assessed hippocampal and callosal anatomy in PSAPP (PS1xAPP) mice, another transgenic mouse model of AD, and found no major abnormalities. We then used fluorodeoxyglucose (FDG) autoradiography in older and younger PSAPP and wildtype mice to assess the functional state of 56 regions-of-interest across group, age and increasing amyloid load. Reductions in FDG uptake in aged transgenic mice, with significant interactions between group and age, were found in retrosplenial cingulate gyrus, found to be metabolically affected in persons affected by or at risk for AD, and in brain regions known to participate with retrosplenial cingulate in networks contributing to spatial learning deficits found in these animals. Like patients with AD, PSAPP mice have age-related metabolic reductions in posterior cingulate cortex, a finding that does not appear to be related to morphological abnormalities. If longitudinal studies support these progressive and preferential reductions in retrosplenial metabolism in PSAPP mice, these reductions could provide an indicator of disease progression, help bridge the gap between human and animal studies of AD, and aid in clarification of disease mechanisms and screening of promising treatments.

[1]  J. Hardy,et al.  Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease , 2000, Nature.

[2]  D. Diamond,et al.  Correlation between cognitive deficits and Aβ deposits in transgenic APP+PS1 mice , 2001, Neurobiology of Aging.

[3]  S. Younkin,et al.  Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice , 1996, Science.

[4]  D. Bredesen,et al.  Correction for Galvan et al., Reversal of Alzheimer's-like pathology and behavior in human APP transgenic mice by mutation of Asp664 , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[5]  R. Koeppe,et al.  A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[6]  F. Gonzalez-Lima,et al.  Nonprogressive transgene-related callosal and hippocampal changes in PDAPP mice , 2006, Neuroreport.

[7]  G. Alexander,et al.  Declining brain activity in cognitively normal apolipoprotein E ɛ4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[8]  F. Gonzalez-Lima,et al.  Reduced corpus callosum, fornix and hippocampus in PDAPP transgenic mouse model of Alzheimer's disease , 2001, Neuroreport.

[9]  J. Aggleton,et al.  The effects of selective lesions within the anterior thalamic nuclei on spatial memory in the rat , 1996, Behavioural Brain Research.

[10]  S. Thibodeau,et al.  Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. , 1996, The New England journal of medicine.

[11]  J. Aggleton,et al.  Evidence of a Spatial Encoding Deficit in Rats with Lesions of the Mammillary Bodies or Mammillothalamic Tract , 2003, The Journal of Neuroscience.

[12]  F. Gonzalez-Lima,et al.  Quantitative histochemistry of cytochrome oxidase in rat brain , 1991, Neuroscience Letters.

[13]  G M Rose,et al.  Exposing rats to a predator impairs spatial working memory in the radial arm water maze , 1999, Hippocampus.

[14]  N. Foster,et al.  Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease , 1997, Annals of neurology.

[15]  J. Hardy,et al.  Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1 , 1996, Nature.

[16]  F Gonzalez-Lima,et al.  Tracking Alzheimer's disease in transgenic mice using fluorodeoxyglucose autoradiography , 2000, Neuroreport.

[17]  Simon R. Cherry,et al.  Effects of Image Resolution on Autoradiographic Measurements of Posterior Cingulate Activity in PDAPP Mice: Implications for Functional Brain Imaging Studies of Transgenic Mouse Models of Alzheimer's Disease , 2002, NeuroImage.

[18]  Satoshi Minoshima,et al.  Posterior cingulate cortex in Alzheimer's disease , 1994, The Lancet.

[19]  J. Hardy,et al.  Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes , 1998, Nature Medicine.

[20]  George Paxinos,et al.  The Mouse Brain in Stereotaxic Coordinates , 2001 .

[21]  L. Mucke,et al.  Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein , 1995, Nature.

[22]  D. Diamond,et al.  Progressive, age-related behavioral impairments in transgenic mice carrying both mutant amyloid precursor protein and presenilin-1 transgenes , 2001, Brain Research.

[23]  L. Aitkin,et al.  Plasticity of auditory cortex associated with sensorineural hearing loss in adult C57BL/6J mice , 1993, The Journal of comparative neurology.

[24]  C. Almeida,et al.  Intraneuronal Aβ accumulation and origin of plaques in Alzheimer's disease , 2005, Neurobiology of Aging.

[25]  J. Caston,et al.  Differential Roles of Cerebellar Cortex and Deep Cerebellar Nuclei in Learning and Retention of a Spatial Task: Studies in Intact and Cerebellectomized Lurcher Mutant Mice , 1998, Behavior genetics.

[26]  F Gonzalez-Lima,et al.  Energy Hypometabolism in Posterior Cingulate Cortex of Alzheimer's Patients: Superficial Laminar Cytochrome Oxidase Associated with Disease Duration , 2001, The Journal of Neuroscience.

[27]  G. Alexander,et al.  Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[28]  K Herholz,et al.  Clinical deterioration in probable Alzheimer's disease correlates with progressive metabolic impairment of association areas. , 1994, Dementia.

[29]  M. W. Brown,et al.  Fos expression in the rostral thalamic nuclei and associated cortical regions in response to different spatial memory tests , 2000, Neuroscience.